Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
OBJECTIVE
Congenital adrenal hyperplasia (CAH) patients are at a higher risk to develop obesity. The role of leptin in CAH is still controversial. Our study aimed to evaluate serum levels of leptin, the soluble leptin receptor (sOB-R), and the sOB-R: leptin molar ratios in a cohort of CAH children and adolescents, and their associations with clinical and metabolic parameters.


METHODS
We studied 51 CAH patients, aged 5.6-19.6 years (median 11.8, n=30 females) cross-sectionally. All patients had genetically proven CAH and received standard steroid substitution therapy. Blood specimens were taken after overnight fasting between 0800 and 1000 h. For the analyses of leptin and sOB-R, matched pairs were built with healthy Caucasian patients for sex, Tanner stage (TS), chronologic age (CA), and body mass index (BMI).


RESULTS
BMI and SDS were significantly elevated compared with the reference population. Leptin levels were not different between matched pairs, whereas sOB-R levels were significantly lower in CAH. Consequently, the sOB-R: leptin molar ratios were significantly decreased in CAH. Correlation analyses in CAH patients revealed significant relationship between leptin and CA, TS, BMI, and homeostasis model assessment of insulin resistance. Similar results were obtained for the matched control group. For sOB-R, we found no significant correlation for CA, TS, or BMI in CAH, but we did in the controls. There were significant correlations for androgens within the CAH group. Additional analyses revealed no correlation with steroid medication or metabolic control.


CONCLUSIONS
Our data show that an altered leptin axis with normal serum leptin concentrations but decreased sOB-R serum levels may contribute to the increased risk of overweight and obesity in CAH.
Völkl
Thomas M K
TM
Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University of Erlangen-Nuremberg, Loschgestrasse 15, 91054 Erlangen, Germany.
Simm
Diemud
D
Körner
Antje
A
Rascher
Wolfgang
W
Kiess
Wieland
W
Kratzsch
Jürgen
J
Dörr
Helmuth G
HG
D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000453:epidemiology* / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood*; D008297:Male; D015233:Models, Statistical; D009765:Obesity / Q000453:epidemiology* / Q000378:metabolism*; D050177:Overweight / Q000453:epidemiology / Q000378:metabolism; D011279:Pregnanetriol / Q000652:urine; D011446:Prospective Studies; D054411:Receptors, Leptin / Q000097:blood; D012307:Risk Factors; D013255:Steroid 21-Hydroxylase / Q000378:metabolism; D013739:Testosterone / Q000097:blood; D055815:Young Adult
D020738:Leptin; D054411:Receptors, Leptin; D011279:Pregnanetriol; D013739:Testosterone; D019326:17-alpha-Hydroxyprogesterone; D013255:Steroid 21-Hydroxylase